There is still so much to grapple with when it comes to COVID-19 and the workplace. That’s why we have partnered with MedHealth and IPAR to bring you ‘bite size’ summaries of some of the most pertinent research in the medical industry, and in particular what the experts are saying about COVID-19 and its ongoing impact in, and on, the workplaces of Australia.

We have also combined our expertise with MedHealth and IPAR to provide a range of solutions to help you support individuals with Long COVID or complex biopsychosocial and psychological needs as a result of the pandemic. Find out more about our COVID Supports here.

Read the individual articles from our latest newsletter below, or view the full fifth edition of the COVID Matters newsletter here.

Articles from Issue 05

COVID-19 vaccine surveillance report

Published in late January 2022, this report presents data on COVID-19 cases, hospitalisations and deaths by vaccination status in the UK. The ‘vaccine effectiveness’ section of the report is our focus.

COVID-19: UK approves Novavax’s protein based vaccine 

The UK’s regulator approved Novavax’s COVID-19 vaccine, following it’s approval by the European Medicines Agency in December 2021. This vaccine has also recently been approved for use in Australia for people 18 years and over. The novel COVID-19 vaccine may prove attractive to people who are reluctant to be vaccinated by other available options, as it is a protein-based vaccine which is an established technology. The paper describes the ‘journey of Novavax’ as a vaccine and the delays associated with its development and approval.

Diagnostic strategies for endemic Coronavirus Disease 2019 (COVID-19)

COVID-19 rapid antigen tests generate fast and immediately actionable results. They quickly confirm COVID-19, but weakly rule out infection as their sensitivity is not as high as other testing methods. Test performance depends on the prevalence in the community and testing protocol. The move toward the global endemic phase calls for high quality, low cost and user-friendly testing methods. This research provides a few important recommendations or diagnostic strategies to help us work toward this goal.

How to overcome return-to-office resistance

Although the pandemic has been a once-in-a-century disruption to business, navigating this challenge is no different than managing any other kind of organisational change with professional and personal implications.

Insurance Quote

[contact-form-7 id="1142" title="Get a Quote" html_class="sc_form_quote"]